Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3

Abstract Context Current GH therapy requires daily injections, which can be burdensome. Somapacitan is a long-acting GH derivative in development for treatment of GH deficiency (GHD). Objective Evaluate the efficacy, safety, and tolerability of once-weekly somapacitan after 3 years of treatment. Des...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The journal of clinical endocrinology and metabolism Ročník 107; číslo 5; s. 1357 - 1367
Hlavní autori:	Sävendahl, Lars, Battelino, Tadej, Højby Rasmussen, Michael, Brod, Meryl, Saenger, Paul, Horikawa, Reiko
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	US Oxford University Press 01.05.2022
Predmet:	Body Height Child Dwarfism, Pituitary - drug therapy Growth Hormone - therapeutic use Histidine Human Growth Hormone Humans Insulin-Like Growth Factor I - therapeutic use Mannitol Phenol Pituitary Hormones, Anterior long-acting growth hormone growth hormone replacement therapy growth hormone somapacitan childhood growth hormone deficiency growth hormone deficiency
ISSN:	0021-972X, 1945-7197, 1945-7197
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!